I have been following CSL on and off over the years and have general understanding of their business. Can someone explain why this consistently trades at such a high PE like 30+? Is there so much growth in new products in the pipeline which will deliver huge earning growth in the future? etc etc
trump pharma tariffs sure to have a big impact as CSL won’t be able to easily pick up their Melbourne blood plasma plant and move it to the US overnight
Not sure what fair value might be in this macro environment but I am guessing it is not PE 30+ on forward earnings which might be taking a short term hit
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$240.21 |
Change
1.500(0.63%) |
Mkt cap ! $116.3B | |||
| Open | High | Low | Value | Volume |
| $238.71 | $241.05 | $237.37 | $567.1M | 2.283M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1607 | $240.17 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $240.25 | 394 | 1 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| CSL (ASX) Chart |